Finally, because patients were not mandatorily tested for tumor PD-1/PD-L1 expression status prior to receiving ICIs, PD-1/PD-L1 status characteristics were not taken into account in the discussion, which may interfere with the comprehensiveness of the study. The gene discussed is CD274; the disease is neoplasm.